nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—prostate cancer—testicular cancer	0.508	1	CtDrD
Conjugated Estrogens—ABCC11—Methotrexate—testicular cancer	0.0374	0.0996	CbGbCtD
Conjugated Estrogens—SLCO1A2—Chlorambucil—testicular cancer	0.0316	0.0841	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—testicular cancer	0.0257	0.0684	CbGbCtD
Conjugated Estrogens—ABCC1—Dactinomycin—testicular cancer	0.017	0.0453	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—testicular cancer	0.0164	0.0437	CbGbCtD
Conjugated Estrogens—ABCC3—Cisplatin—testicular cancer	0.0159	0.0423	CbGbCtD
Conjugated Estrogens—ABCC3—Etoposide—testicular cancer	0.0156	0.0416	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—testicular cancer	0.0123	0.0328	CbGbCtD
Conjugated Estrogens—ABCG2—Dactinomycin—testicular cancer	0.0114	0.0303	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—testicular cancer	0.0106	0.0284	CbGbCtD
Conjugated Estrogens—ABCC1—Vinblastine—testicular cancer	0.0106	0.0283	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—testicular cancer	0.0103	0.0275	CbGbCtD
Conjugated Estrogens—ABCC1—Etoposide—testicular cancer	0.00959	0.0255	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—testicular cancer	0.00916	0.0244	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—testicular cancer	0.00847	0.0226	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—testicular cancer	0.00845	0.0225	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—testicular cancer	0.00788	0.021	CbGbCtD
Conjugated Estrogens—ABCC2—Vinblastine—testicular cancer	0.00788	0.021	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—testicular cancer	0.00764	0.0204	CbGbCtD
Conjugated Estrogens—ABCC2—Cisplatin—testicular cancer	0.00722	0.0192	CbGbCtD
Conjugated Estrogens—ABCC2—Etoposide—testicular cancer	0.0071	0.0189	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—testicular cancer	0.00654	0.0174	CbGbCtD
Conjugated Estrogens—ABCG2—Cisplatin—testicular cancer	0.00653	0.0174	CbGbCtD
Conjugated Estrogens—ABCG2—Etoposide—testicular cancer	0.00641	0.0171	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—testicular cancer	0.00633	0.0169	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—testicular cancer	0.00565	0.0151	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—testicular cancer	0.00533	0.0142	CbGbCtD
Conjugated Estrogens—ESR2—seminiferous tubule of testis—testicular cancer	0.00529	0.172	CbGeAlD
Conjugated Estrogens—SLC22A8—Methotrexate—testicular cancer	0.00492	0.0131	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—testicular cancer	0.00484	0.0129	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—testicular cancer	0.00469	0.0125	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—testicular cancer	0.00438	0.0117	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—testicular cancer	0.00424	0.0113	CbGbCtD
Conjugated Estrogens—ABCB1—Dactinomycin—testicular cancer	0.0041	0.0109	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—testicular cancer	0.00343	0.00914	CbGbCtD
Conjugated Estrogens—CYP3A4—Ifosfamide—testicular cancer	0.0029	0.00773	CbGbCtD
Conjugated Estrogens—CYP1A2—Etoposide—testicular cancer	0.00265	0.00705	CbGbCtD
Conjugated Estrogens—ABCB1—Vinblastine—testicular cancer	0.00257	0.00684	CbGbCtD
Conjugated Estrogens—ABCB1—Cisplatin—testicular cancer	0.00235	0.00627	CbGbCtD
Conjugated Estrogens—ABCB1—Etoposide—testicular cancer	0.00231	0.00616	CbGbCtD
Conjugated Estrogens—ESR2—Ovarian Infertility Genes—DAZL—testicular cancer	0.00205	0.209	CbGpPWpGaD
Conjugated Estrogens—ABCC11—embryo—testicular cancer	0.0019	0.0616	CbGeAlD
Conjugated Estrogens—ABCB1—Doxorubicin—testicular cancer	0.00158	0.0042	CbGbCtD
Conjugated Estrogens—CYP3A4—Vinblastine—testicular cancer	0.00154	0.0041	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—testicular cancer	0.00153	0.00407	CbGbCtD
Conjugated Estrogens—CYP3A4—Etoposide—testicular cancer	0.00139	0.00369	CbGbCtD
Conjugated Estrogens—ABCC11—gonad—testicular cancer	0.00129	0.0418	CbGeAlD
Conjugated Estrogens—ABCC11—female gonad—testicular cancer	0.00105	0.034	CbGeAlD
Conjugated Estrogens—SLC51B—testis—testicular cancer	0.00104	0.0338	CbGeAlD
Conjugated Estrogens—SLC51A—gonad—testicular cancer	0.00104	0.0336	CbGeAlD
Conjugated Estrogens—CYP3A4—Doxorubicin—testicular cancer	0.000945	0.00252	CbGbCtD
Conjugated Estrogens—SLC10A1—seminal vesicle—testicular cancer	0.000929	0.0302	CbGeAlD
Conjugated Estrogens—ABCC11—testis—testicular cancer	0.000928	0.0301	CbGeAlD
Conjugated Estrogens—SLCO3A1—seminal vesicle—testicular cancer	0.000768	0.0249	CbGeAlD
Conjugated Estrogens—SLC51A—testis—testicular cancer	0.000746	0.0242	CbGeAlD
Conjugated Estrogens—SLCO4A1—seminal vesicle—testicular cancer	0.0007	0.0227	CbGeAlD
Conjugated Estrogens—SLC10A1—gonad—testicular cancer	0.000671	0.0218	CbGeAlD
Conjugated Estrogens—COMT—seminal vesicle—testicular cancer	0.000591	0.0192	CbGeAlD
Conjugated Estrogens—SLCO3A1—gonad—testicular cancer	0.000555	0.018	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—testicular cancer	0.000541	0.0176	CbGeAlD
Conjugated Estrogens—SLC10A1—testis—testicular cancer	0.000484	0.0157	CbGeAlD
Conjugated Estrogens—SLCO1C1—testis—testicular cancer	0.000455	0.0148	CbGeAlD
Conjugated Estrogens—ESR1—embryo—testicular cancer	0.000452	0.0147	CbGeAlD
Conjugated Estrogens—SLCO3A1—female gonad—testicular cancer	0.000451	0.0146	CbGeAlD
Conjugated Estrogens—ESR2—gonad—testicular cancer	0.000448	0.0146	CbGeAlD
Conjugated Estrogens—COMT—gonad—testicular cancer	0.000427	0.0139	CbGeAlD
Conjugated Estrogens—ABCC1—seminal vesicle—testicular cancer	0.000411	0.0134	CbGeAlD
Conjugated Estrogens—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000409	0.0416	CbGpPWpGaD
Conjugated Estrogens—SLCO3A1—testis—testicular cancer	0.0004	0.013	CbGeAlD
Conjugated Estrogens—SLCO4A1—testis—testicular cancer	0.000364	0.0118	CbGeAlD
Conjugated Estrogens—ESR2—female gonad—testicular cancer	0.000364	0.0118	CbGeAlD
Conjugated Estrogens—SLCO3A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000353	0.036	CbGpPWpGaD
Conjugated Estrogens—COMT—female gonad—testicular cancer	0.000347	0.0113	CbGeAlD
Conjugated Estrogens—ABCC3—female gonad—testicular cancer	0.000343	0.0111	CbGeAlD
Conjugated Estrogens—ABCG2—seminal vesicle—testicular cancer	0.00034	0.0111	CbGeAlD
Conjugated Estrogens—SLCO4A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000337	0.0343	CbGpPWpGaD
Conjugated Estrogens—SLCO1C1—lymph node—testicular cancer	0.00033	0.0107	CbGeAlD
Conjugated Estrogens—ESR2—testis—testicular cancer	0.000323	0.0105	CbGeAlD
Conjugated Estrogens—SLCO2B1—female gonad—testicular cancer	0.00032	0.0104	CbGeAlD
Conjugated Estrogens—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000312	0.0317	CbGpPWpGaD
Conjugated Estrogens—COMT—testis—testicular cancer	0.000308	0.01	CbGeAlD
Conjugated Estrogens—ESR1—gonad—testicular cancer	0.000307	0.00997	CbGeAlD
Conjugated Estrogens—ABCC3—testis—testicular cancer	0.000304	0.00988	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—testicular cancer	0.00029	0.00942	CbGeAlD
Conjugated Estrogens—ABCC11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000286	0.0291	CbGpPWpGaD
Conjugated Estrogens—SLCO2B1—testis—testicular cancer	0.000284	0.00921	CbGeAlD
Conjugated Estrogens—ABCC4—female gonad—testicular cancer	0.000283	0.0092	CbGeAlD
Conjugated Estrogens—SLCO1C1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000283	0.0288	CbGpPWpGaD
Conjugated Estrogens—SLCO4A1—lymph node—testicular cancer	0.000264	0.00858	CbGeAlD
Conjugated Estrogens—SLCO1A2—testis—testicular cancer	0.000261	0.00847	CbGeAlD
Conjugated Estrogens—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00026	0.0265	CbGpPWpGaD
Conjugated Estrogens—ABCC4—testis—testicular cancer	0.000251	0.00816	CbGeAlD
Conjugated Estrogens—ESR1—female gonad—testicular cancer	0.00025	0.0081	CbGeAlD
Conjugated Estrogens—ABCC4—Ectoderm Differentiation—TFAP2C—testicular cancer	0.000246	0.0251	CbGpPWpGaD
Conjugated Estrogens—ABCC2—testis—testicular cancer	0.000243	0.00789	CbGeAlD
Conjugated Estrogens—ABCC1—female gonad—testicular cancer	0.000241	0.00784	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—testicular cancer	0.000234	0.00761	CbGeAlD
Conjugated Estrogens—ABCC3—NRF2 pathway—SLC2A6—testicular cancer	0.000229	0.0233	CbGpPWpGaD
Conjugated Estrogens—COMT—lymph node—testicular cancer	0.000223	0.00725	CbGeAlD
Conjugated Estrogens—ESR1—testis—testicular cancer	0.000221	0.00719	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—testicular cancer	0.000221	0.00716	CbGeAlD
Conjugated Estrogens—ABCC4—NRF2 pathway—SLC2A6—testicular cancer	0.000215	0.0219	CbGpPWpGaD
Conjugated Estrogens—ABCC1—testis—testicular cancer	0.000214	0.00695	CbGeAlD
Conjugated Estrogens—SLCO2B1—lymph node—testicular cancer	0.000206	0.00668	CbGeAlD
Conjugated Estrogens—SLCO2B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000205	0.0209	CbGpPWpGaD
Conjugated Estrogens—ABCG2—female gonad—testicular cancer	0.0002	0.00649	CbGeAlD
Conjugated Estrogens—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000186	0.0189	CbGpPWpGaD
Conjugated Estrogens—ABCC4—lymph node—testicular cancer	0.000182	0.00591	CbGeAlD
Conjugated Estrogens—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000182	0.0185	CbGpPWpGaD
Conjugated Estrogens—SLCO3A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00018	0.0183	CbGpPWpGaD
Conjugated Estrogens—ABCB1—embryo—testicular cancer	0.000179	0.0058	CbGeAlD
Conjugated Estrogens—ABCG2—testis—testicular cancer	0.000177	0.00576	CbGeAlD
Conjugated Estrogens—ABCC2—lymph node—testicular cancer	0.000176	0.00572	CbGeAlD
Conjugated Estrogens—SLCO4A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000171	0.0175	CbGpPWpGaD
Conjugated Estrogens—COMT—Phase II conjugation—HPGDS—testicular cancer	0.000169	0.0172	CbGpPWpGaD
Conjugated Estrogens—ABCB1—seminal vesicle—testicular cancer	0.000168	0.00545	CbGeAlD
Conjugated Estrogens—ESR1—lymph node—testicular cancer	0.00016	0.00521	CbGeAlD
Conjugated Estrogens—SLCO1B3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00016	0.0163	CbGpPWpGaD
Conjugated Estrogens—ABCC1—lymph node—testicular cancer	0.000155	0.00504	CbGeAlD
Conjugated Estrogens—ABCC1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000154	0.0156	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000148	0.015	CbGpPWpGaD
Conjugated Estrogens—SLCO1C1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000144	0.0146	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000142	0.0144	CbGpPWpGaD
Conjugated Estrogens—ESR2—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	0.00013	0.0133	CbGpPWpGaD
Conjugated Estrogens—ABCG2—lymph node—testicular cancer	0.000128	0.00417	CbGeAlD
Conjugated Estrogens—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000126	0.0128	CbGpPWpGaD
Conjugated Estrogens—ABCB1—gonad—testicular cancer	0.000121	0.00394	CbGeAlD
Conjugated Estrogens—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000118	0.012	CbGpPWpGaD
Conjugated Estrogens—ESR1—LKB1 signaling events—STK11—testicular cancer	0.000113	0.0115	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000108	0.0109	CbGpPWpGaD
Conjugated Estrogens—SLCO2B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000104	0.0106	CbGpPWpGaD
Conjugated Estrogens—COMT—Biological oxidations—HPGDS—testicular cancer	9.89e-05	0.0101	CbGpPWpGaD
Conjugated Estrogens—ABCB1—female gonad—testicular cancer	9.86e-05	0.0032	CbGeAlD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.43e-05	0.00961	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	9.37e-05	0.00954	CbGpPWpGaD
Conjugated Estrogens—ABCB1—testis—testicular cancer	8.74e-05	0.00284	CbGeAlD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	8.13e-05	0.00828	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.34e-05	0.00747	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.19e-05	0.00733	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6.9e-05	0.00703	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	6.81e-05	0.00693	CbGpPWpGaD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	6.58e-05	0.0067	CbGpPWpGaD
Conjugated Estrogens—ESR1—FOXM1 transcription factor network—MMP2—testicular cancer	6.45e-05	0.00657	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6.39e-05	0.00651	CbGpPWpGaD
Conjugated Estrogens—ABCB1—lymph node—testicular cancer	6.34e-05	0.00206	CbGeAlD
Conjugated Estrogens—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	6.3e-05	0.00642	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	6.23e-05	0.00635	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6e-05	0.00612	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	5.83e-05	0.00594	CbGpPWpGaD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.82e-05	0.00592	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.75e-05	0.00586	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.46e-05	0.00556	CbGpPWpGaD
Conjugated Estrogens—Pancreatitis—Doxorubicin—testicular cancer	5.22e-05	0.000685	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Etoposide—testicular cancer	5.2e-05	0.000683	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Epirubicin—testicular cancer	5.19e-05	0.000681	CcSEcCtD
Conjugated Estrogens—Somnolence—Etoposide—testicular cancer	5.19e-05	0.000681	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—testicular cancer	5.18e-05	0.000681	CcSEcCtD
Conjugated Estrogens—Nausea—Bleomycin—testicular cancer	5.14e-05	0.000674	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Epirubicin—testicular cancer	5.13e-05	0.000674	CcSEcCtD
Conjugated Estrogens—Infestation—Epirubicin—testicular cancer	5.13e-05	0.000674	CcSEcCtD
Conjugated Estrogens—Vomiting—Dactinomycin—testicular cancer	5.13e-05	0.000673	CcSEcCtD
Conjugated Estrogens—Bronchitis—Doxorubicin—testicular cancer	5.12e-05	0.000672	CcSEcCtD
Conjugated Estrogens—Rash—Dactinomycin—testicular cancer	5.09e-05	0.000668	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Etoposide—testicular cancer	5.07e-05	0.000666	CcSEcCtD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.06e-05	0.00515	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Ifosfamide—testicular cancer	5.06e-05	0.000664	CcSEcCtD
Conjugated Estrogens—Renal failure—Epirubicin—testicular cancer	5.04e-05	0.000662	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Etoposide—testicular cancer	5.04e-05	0.000662	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cisplatin—testicular cancer	5.04e-05	0.000661	CcSEcCtD
Conjugated Estrogens—Fatigue—Etoposide—testicular cancer	5.03e-05	0.000661	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Epirubicin—testicular cancer	5.03e-05	0.00066	CcSEcCtD
Conjugated Estrogens—Pain—Etoposide—testicular cancer	4.99e-05	0.000655	CcSEcCtD
Conjugated Estrogens—Constipation—Etoposide—testicular cancer	4.99e-05	0.000655	CcSEcCtD
Conjugated Estrogens—Dysuria—Doxorubicin—testicular cancer	4.98e-05	0.000654	CcSEcCtD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.96e-05	0.00505	CbGpPWpGaD
Conjugated Estrogens—Upper respiratory tract infection—Doxorubicin—testicular cancer	4.95e-05	0.00065	CcSEcCtD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—MMP2—testicular cancer	4.92e-05	0.00501	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Ifosfamide—testicular cancer	4.89e-05	0.000642	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—testicular cancer	4.88e-05	0.000641	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Epirubicin—testicular cancer	4.85e-05	0.000637	CcSEcCtD
Conjugated Estrogens—Weight increased—Doxorubicin—testicular cancer	4.85e-05	0.000636	CcSEcCtD
Conjugated Estrogens—Sinusitis—Epirubicin—testicular cancer	4.81e-05	0.000632	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Doxorubicin—testicular cancer	4.8e-05	0.00063	CcSEcCtD
Conjugated Estrogens—Nausea—Dactinomycin—testicular cancer	4.79e-05	0.000629	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Etoposide—testicular cancer	4.77e-05	0.000627	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Doxorubicin—testicular cancer	4.75e-05	0.000623	CcSEcCtD
Conjugated Estrogens—Infestation—Doxorubicin—testicular cancer	4.75e-05	0.000623	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—testicular cancer	4.74e-05	0.000623	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	4.73e-05	0.00481	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Ifosfamide—testicular cancer	4.7e-05	0.000617	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cisplatin—testicular cancer	4.69e-05	0.000616	CcSEcCtD
Conjugated Estrogens—ESR2—Gene Expression—DNMT3L—testicular cancer	4.68e-05	0.00477	CbGpPWpGaD
Conjugated Estrogens—Renal failure—Doxorubicin—testicular cancer	4.67e-05	0.000613	CcSEcCtD
Conjugated Estrogens—Rash—Ifosfamide—testicular cancer	4.66e-05	0.000612	CcSEcCtD
Conjugated Estrogens—Dermatitis—Ifosfamide—testicular cancer	4.66e-05	0.000611	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—testicular cancer	4.65e-05	0.000611	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Doxorubicin—testicular cancer	4.65e-05	0.000611	CcSEcCtD
Conjugated Estrogens—Urticaria—Etoposide—testicular cancer	4.64e-05	0.000609	CcSEcCtD
Conjugated Estrogens—Rhinitis—Epirubicin—testicular cancer	4.62e-05	0.000606	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Etoposide—testicular cancer	4.61e-05	0.000606	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Etoposide—testicular cancer	4.61e-05	0.000606	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—testicular cancer	4.6e-05	0.000604	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Epirubicin—testicular cancer	4.58e-05	0.000602	CcSEcCtD
Conjugated Estrogens—Asthenia—Cisplatin—testicular cancer	4.57e-05	0.0006	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Epirubicin—testicular cancer	4.57e-05	0.0006	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—testicular cancer	4.57e-05	0.0006	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Epirubicin—testicular cancer	4.54e-05	0.000596	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—testicular cancer	4.49e-05	0.000589	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—testicular cancer	4.46e-05	0.000586	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—testicular cancer	4.45e-05	0.000585	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—testicular cancer	4.45e-05	0.000584	CcSEcCtD
Conjugated Estrogens—Visual impairment—Epirubicin—testicular cancer	4.44e-05	0.000583	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—testicular cancer	4.44e-05	0.000582	CcSEcCtD
Conjugated Estrogens—Nausea—Ifosfamide—testicular cancer	4.39e-05	0.000576	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cisplatin—testicular cancer	4.36e-05	0.000572	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—testicular cancer	4.35e-05	0.000572	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—testicular cancer	4.35e-05	0.000571	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—testicular cancer	4.31e-05	0.000566	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—testicular cancer	4.3e-05	0.000565	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Etoposide—testicular cancer	4.3e-05	0.000565	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—testicular cancer	4.28e-05	0.000562	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—testicular cancer	4.28e-05	0.000562	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—testicular cancer	4.27e-05	0.000561	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—testicular cancer	4.27e-05	0.000561	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—testicular cancer	4.24e-05	0.000557	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—testicular cancer	4.23e-05	0.000555	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—testicular cancer	4.2e-05	0.000551	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—testicular cancer	4.2e-05	0.000551	CcSEcCtD
Conjugated Estrogens—Asthenia—Etoposide—testicular cancer	4.19e-05	0.00055	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—testicular cancer	4.18e-05	0.000549	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—testicular cancer	4.16e-05	0.000546	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—testicular cancer	4.15e-05	0.000545	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—testicular cancer	4.14e-05	0.000544	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—STK11—testicular cancer	4.14e-05	0.00422	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Etoposide—testicular cancer	4.13e-05	0.000542	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Epirubicin—testicular cancer	4.11e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—testicular cancer	4.11e-05	0.000539	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—testicular cancer	4.07e-05	0.000534	CcSEcCtD
Conjugated Estrogens—Vomiting—Cisplatin—testicular cancer	4.05e-05	0.000532	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—testicular cancer	4.04e-05	0.00053	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—testicular cancer	4.03e-05	0.00053	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—testicular cancer	4.03e-05	0.000529	CcSEcCtD
Conjugated Estrogens—Rash—Cisplatin—testicular cancer	4.02e-05	0.000527	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cisplatin—testicular cancer	4.01e-05	0.000527	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—testicular cancer	4.01e-05	0.000526	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—testicular cancer	4.01e-05	0.000526	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Etoposide—testicular cancer	3.99e-05	0.000524	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—testicular cancer	3.98e-05	0.000523	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—testicular cancer	3.95e-05	0.000519	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—testicular cancer	3.95e-05	0.000519	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—testicular cancer	3.93e-05	0.000517	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—testicular cancer	3.93e-05	0.000515	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—testicular cancer	3.89e-05	0.000511	CcSEcCtD
Conjugated Estrogens—Back pain—Epirubicin—testicular cancer	3.88e-05	0.000509	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—testicular cancer	3.87e-05	0.000508	CcSEcCtD
Conjugated Estrogens—Dizziness—Etoposide—testicular cancer	3.86e-05	0.000507	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—testicular cancer	3.85e-05	0.000506	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—testicular cancer	3.85e-05	0.000505	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—testicular cancer	3.85e-05	0.000505	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—testicular cancer	3.84e-05	0.000504	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—KITLG—testicular cancer	3.81e-05	0.00388	CbGpPWpGaD
Conjugated Estrogens—Arrhythmia—Doxorubicin—testicular cancer	3.81e-05	0.0005	CcSEcCtD
Conjugated Estrogens—Nausea—Cisplatin—testicular cancer	3.78e-05	0.000497	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—testicular cancer	3.78e-05	0.000496	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—testicular cancer	3.77e-05	0.000494	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—testicular cancer	3.74e-05	0.000491	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—testicular cancer	3.73e-05	0.00049	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—testicular cancer	3.71e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Vomiting—Etoposide—testicular cancer	3.71e-05	0.000487	CcSEcCtD
Conjugated Estrogens—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	3.71e-05	0.00378	CbGpPWpGaD
Conjugated Estrogens—Erythema—Doxorubicin—testicular cancer	3.71e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—testicular cancer	3.71e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Rash—Etoposide—testicular cancer	3.68e-05	0.000483	CcSEcCtD
Conjugated Estrogens—Dermatitis—Etoposide—testicular cancer	3.68e-05	0.000483	CcSEcCtD
Conjugated Estrogens—Headache—Etoposide—testicular cancer	3.66e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—testicular cancer	3.66e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—testicular cancer	3.65e-05	0.000479	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—testicular cancer	3.65e-05	0.000479	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—testicular cancer	3.65e-05	0.000479	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—testicular cancer	3.64e-05	0.000478	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Doxorubicin—testicular cancer	3.63e-05	0.000477	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	3.62e-05	0.000476	CcSEcCtD
Conjugated Estrogens—Nervousness—Doxorubicin—testicular cancer	3.6e-05	0.000473	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—testicular cancer	3.6e-05	0.000473	CcSEcCtD
Conjugated Estrogens—Syncope—Epirubicin—testicular cancer	3.6e-05	0.000472	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—testicular cancer	3.59e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—testicular cancer	3.57e-05	0.000468	CcSEcCtD
Conjugated Estrogens—Palpitations—Epirubicin—testicular cancer	3.54e-05	0.000465	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Epirubicin—testicular cancer	3.52e-05	0.000463	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—testicular cancer	3.5e-05	0.000459	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—testicular cancer	3.5e-05	0.000459	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—testicular cancer	3.5e-05	0.000459	CcSEcCtD
Conjugated Estrogens—Convulsion—Epirubicin—testicular cancer	3.47e-05	0.000456	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—testicular cancer	3.47e-05	0.000456	CcSEcCtD
Conjugated Estrogens—Nausea—Etoposide—testicular cancer	3.47e-05	0.000455	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	3.43e-05	0.0035	CbGpPWpGaD
Conjugated Estrogens—Nervous system disorder—Methotrexate—testicular cancer	3.43e-05	0.00045	CcSEcCtD
Conjugated Estrogens—Chest pain—Epirubicin—testicular cancer	3.41e-05	0.000448	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—testicular cancer	3.41e-05	0.000448	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—testicular cancer	3.41e-05	0.000448	CcSEcCtD
Conjugated Estrogens—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	3.41e-05	0.00347	CbGpPWpGaD
Conjugated Estrogens—Anxiety—Epirubicin—testicular cancer	3.4e-05	0.000447	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—testicular cancer	3.4e-05	0.000446	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	3.39e-05	0.000445	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—testicular cancer	3.38e-05	0.000444	CcSEcCtD
Conjugated Estrogens—Vertigo—Doxorubicin—testicular cancer	3.33e-05	0.000438	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—testicular cancer	3.33e-05	0.000438	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—testicular cancer	3.33e-05	0.000437	CcSEcCtD
Conjugated Estrogens—Palpitations—Doxorubicin—testicular cancer	3.28e-05	0.00043	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—testicular cancer	3.27e-05	0.00043	CcSEcCtD
Conjugated Estrogens—Oedema—Epirubicin—testicular cancer	3.27e-05	0.00043	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—testicular cancer	3.27e-05	0.000429	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—testicular cancer	3.26e-05	0.000428	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—testicular cancer	3.25e-05	0.000427	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—testicular cancer	3.24e-05	0.000425	CcSEcCtD
Conjugated Estrogens—Shock—Epirubicin—testicular cancer	3.22e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—testicular cancer	3.21e-05	0.000422	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—testicular cancer	3.21e-05	0.000421	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—testicular cancer	3.19e-05	0.000419	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—testicular cancer	3.19e-05	0.000418	CcSEcCtD
Conjugated Estrogens—Skin disorder—Epirubicin—testicular cancer	3.18e-05	0.000417	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—testicular cancer	3.16e-05	0.000415	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—testicular cancer	3.16e-05	0.000415	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—testicular cancer	3.16e-05	0.000415	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—testicular cancer	3.16e-05	0.000415	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—testicular cancer	3.16e-05	0.000415	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—testicular cancer	3.15e-05	0.000413	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—testicular cancer	3.14e-05	0.000412	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	3.14e-05	0.000412	CcSEcCtD
Conjugated Estrogens—Anorexia—Epirubicin—testicular cancer	3.12e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—testicular cancer	3.12e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—testicular cancer	3.11e-05	0.000408	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.1e-05	0.00316	CbGpPWpGaD
Conjugated Estrogens—Dyspepsia—Methotrexate—testicular cancer	3.08e-05	0.000404	CcSEcCtD
Conjugated Estrogens—Hypotension—Epirubicin—testicular cancer	3.06e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—testicular cancer	3.04e-05	0.000399	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—testicular cancer	3.03e-05	0.000397	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—testicular cancer	3.03e-05	0.000397	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—testicular cancer	3.02e-05	0.000396	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—testicular cancer	3.01e-05	0.000396	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—testicular cancer	3.01e-05	0.000395	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—testicular cancer	2.99e-05	0.000393	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—testicular cancer	2.98e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—testicular cancer	2.98e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—testicular cancer	2.97e-05	0.00039	CcSEcCtD
Conjugated Estrogens—Insomnia—Epirubicin—testicular cancer	2.96e-05	0.000389	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—testicular cancer	2.95e-05	0.000388	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—testicular cancer	2.94e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—testicular cancer	2.94e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—testicular cancer	2.93e-05	0.000384	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—testicular cancer	2.92e-05	0.000383	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—testicular cancer	2.91e-05	0.000382	CcSEcCtD
Conjugated Estrogens—Anorexia—Doxorubicin—testicular cancer	2.89e-05	0.000379	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—testicular cancer	2.88e-05	0.000378	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—testicular cancer	2.86e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Epirubicin—testicular cancer	2.84e-05	0.000373	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—FGFR3—testicular cancer	2.83e-05	0.00289	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Doxorubicin—testicular cancer	2.83e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—testicular cancer	2.82e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—testicular cancer	2.82e-05	0.00037	CcSEcCtD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.8e-05	0.00285	CbGpPWpGaD
Conjugated Estrogens—Constipation—Epirubicin—testicular cancer	2.8e-05	0.000367	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—testicular cancer	2.8e-05	0.000367	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—testicular cancer	2.78e-05	0.000365	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—testicular cancer	2.76e-05	0.000363	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—testicular cancer	2.76e-05	0.000363	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—testicular cancer	2.76e-05	0.000362	CcSEcCtD
Conjugated Estrogens—Insomnia—Doxorubicin—testicular cancer	2.74e-05	0.000359	CcSEcCtD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	2.73e-05	0.00279	CbGpPWpGaD
Conjugated Estrogens—Paraesthesia—Doxorubicin—testicular cancer	2.72e-05	0.000357	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—testicular cancer	2.7e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—testicular cancer	2.69e-05	0.000353	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—testicular cancer	2.68e-05	0.000351	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—testicular cancer	2.66e-05	0.00035	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—testicular cancer	2.63e-05	0.000346	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—testicular cancer	2.61e-05	0.000343	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—testicular cancer	2.61e-05	0.000343	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—KIT—testicular cancer	2.6e-05	0.00265	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Epirubicin—testicular cancer	2.6e-05	0.000341	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—testicular cancer	2.59e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—testicular cancer	2.59e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—testicular cancer	2.59e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—testicular cancer	2.59e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—testicular cancer	2.58e-05	0.000338	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—testicular cancer	2.51e-05	0.000329	CcSEcCtD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	2.5e-05	0.00255	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—testicular cancer	2.48e-05	0.000325	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—testicular cancer	2.47e-05	0.000325	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.44e-05	0.00248	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Epirubicin—testicular cancer	2.41e-05	0.000316	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—testicular cancer	2.41e-05	0.000316	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—testicular cancer	2.39e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—testicular cancer	2.39e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—testicular cancer	2.39e-05	0.000314	CcSEcCtD
Conjugated Estrogens—ESR1—Gene Expression—DNMT3L—testicular cancer	2.36e-05	0.0024	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Epirubicin—testicular cancer	2.35e-05	0.000308	CcSEcCtD
Conjugated Estrogens—Pruritus—Epirubicin—testicular cancer	2.31e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—testicular cancer	2.31e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Epirubicin—testicular cancer	2.24e-05	0.000294	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—testicular cancer	2.23e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—testicular cancer	2.22e-05	0.000292	CcSEcCtD
Conjugated Estrogens—SLC10A1—Metabolism—HPGDS—testicular cancer	2.21e-05	0.00225	CbGpPWpGaD
Conjugated Estrogens—Rash—Methotrexate—testicular cancer	2.2e-05	0.000289	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—testicular cancer	2.2e-05	0.000289	CcSEcCtD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.19e-05	0.00224	CbGpPWpGaD
Conjugated Estrogens—Headache—Methotrexate—testicular cancer	2.19e-05	0.000288	CcSEcCtD
Conjugated Estrogens—Asthenia—Doxorubicin—testicular cancer	2.17e-05	0.000285	CcSEcCtD
Conjugated Estrogens—CYP1A2—Biological oxidations—HPGDS—testicular cancer	2.17e-05	0.00221	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Epirubicin—testicular cancer	2.16e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—testicular cancer	2.14e-05	0.000281	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.09e-05	0.00212	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Epirubicin—testicular cancer	2.08e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—testicular cancer	2.08e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—testicular cancer	2.07e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Rash—Epirubicin—testicular cancer	2.06e-05	0.000271	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—testicular cancer	2.06e-05	0.000271	CcSEcCtD
Conjugated Estrogens—Headache—Epirubicin—testicular cancer	2.05e-05	0.000269	CcSEcCtD
Conjugated Estrogens—Dizziness—Doxorubicin—testicular cancer	2e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Nausea—Epirubicin—testicular cancer	1.94e-05	0.000255	CcSEcCtD
Conjugated Estrogens—Vomiting—Doxorubicin—testicular cancer	1.92e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Rash—Doxorubicin—testicular cancer	1.91e-05	0.000251	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—testicular cancer	1.91e-05	0.00025	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—testicular cancer	1.9e-05	0.000249	CcSEcCtD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	1.82e-05	0.00185	CbGpPWpGaD
Conjugated Estrogens—Nausea—Doxorubicin—testicular cancer	1.8e-05	0.000236	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—HPGDS—testicular cancer	1.69e-05	0.00172	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—INSL3—testicular cancer	1.68e-05	0.00171	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Biological oxidations—HPGDS—testicular cancer	1.67e-05	0.00171	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—H2AFZ—testicular cancer	1.64e-05	0.00167	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—STK11—testicular cancer	1.6e-05	0.00163	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—HPGDS—testicular cancer	1.38e-05	0.00141	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—HPGDS—testicular cancer	1.25e-05	0.00127	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—STK11—testicular cancer	1.23e-05	0.00125	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—HPGDS—testicular cancer	1.09e-05	0.00111	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—STK11—testicular cancer	1e-05	0.00102	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—HPGDS—testicular cancer	9.77e-06	0.000995	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—HPGDS—testicular cancer	9.29e-06	0.000946	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—STK11—testicular cancer	9.06e-06	0.000923	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—HPGDS—testicular cancer	8.6e-06	0.000876	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—H2AFZ—testicular cancer	8.53e-06	0.000869	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.33e-06	0.000849	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—H2AFZ—testicular cancer	8.26e-06	0.000841	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—STK11—testicular cancer	7.89e-06	0.000804	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KITLG—testicular cancer	7.85e-06	0.000799	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—STK11—testicular cancer	7.1e-06	0.000723	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—STK11—testicular cancer	6.75e-06	0.000687	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—STK11—testicular cancer	6.25e-06	0.000636	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—FGFR3—testicular cancer	5.83e-06	0.000594	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—H2AFZ—testicular cancer	5.37e-06	0.000547	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KIT—testicular cancer	5.35e-06	0.000545	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STK11—testicular cancer	5.34e-06	0.000544	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KITLG—testicular cancer	4.94e-06	0.000503	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—HPGDS—testicular cancer	4.65e-06	0.000474	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HPGDS—testicular cancer	3.71e-06	0.000378	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGFR3—testicular cancer	3.67e-06	0.000374	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—STK11—testicular cancer	3.38e-06	0.000344	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KIT—testicular cancer	3.37e-06	0.000343	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HPGDS—testicular cancer	2.86e-06	0.000292	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—STK11—testicular cancer	2.7e-06	0.000275	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—STK11—testicular cancer	2.08e-06	0.000212	CbGpPWpGaD
